Inventor · disambiguated record
Werner Bollag
Also filed as: BOLLAG WERNER
30 granted patents·7 pending applications·414 citations·filing 1970–2006
97Inventor score
Top patents by PatentIndex Score
37 records- 0196US4105681A9-phenyl 5,6-dimethyl-nona-2,4,6,8-tetraeonic acid compoundsHOFFMANN LA ROCHE·Filed 1976·Granted Aug 8, 1978·48 cites·18 claims
- 0294US4215215A9-Phenyl-nonate traene compoundsHOFFMANN LA ROCHE·Filed 1979·Granted Jul 29, 1980·38 cites·30 claims
- 0394US3950418AVitamin A acid amidesHOFFMANN LA ROCHE·Filed 1974·Granted Apr 13, 1976·31 cites·8 claims
- 0493US4054589ANovel 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraene estersHOFFMANN LA ROCHE·Filed 1975·Granted Oct 18, 1977·29 cites·6 claims
- 0593US3984440APolyene compoundsHOFFMANN LA ROCHE·Filed 1974·Granted Oct 5, 1976·28 cites·3 claims
- 0682US6326397B1Retinoid antagonists and use thereofHOFFMANN LA ROCHE·Filed 1999·Granted Dec 4, 2001·24 cites·16 claims
- 0782US6133309ATreatment of T-helper cell type 2-mediated immune disease by retinoid antagonistsHOFFMANN LA ROCHE·Filed 1998·Granted Oct 17, 2000·40 cites·37 claims
- 0881US4224244A9-Phenyl 5,6-dimethyl-nona-2,4,6,8 tetraenal or tetraenol derivativesHOFFMANN LA ROCHE·Filed 1979·Granted Sep 23, 1980·9 cites·1 claims
- 0978US4656310ASubstituted triarylphosphonium derivativesHOFFMANN LA ROCHE·Filed 1985·Granted Apr 7, 1987·10 cites·6 claims
- 1077US6610742B1Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonistsHOFFMANN LA ROCHE·Filed 2000·Granted Aug 26, 2003·8 cites·19 claims
- 1177US4565863ARetinoid carbohydratesHOFFMANN LA ROCHE·Filed 1984·Granted Jan 21, 1986·17 cites·23 claims
- 1273US4225527APolyene compoundsHOFFMANN LA ROCHE·Filed 1977·Granted Sep 30, 1980·9 cites·3 claims
- 1365US4316983ANeoplasmic compounds: sugar esters and glycosidesHOFFMANN LA ROCHE·Filed 1980·Granted Feb 23, 1982·9 cites·9 claims
- 1465US4021574AAntidandruff compositions containing 9-(4-lower alkoxy-2,3,6-trilower-alkylphenyl)-3,7-dimethyl-nona-2,4,6,8-tetraen-1-oic acid lower alkyl amidesHOFFMANN LA ROCHE·Filed 1975·Granted May 3, 1977·18 cites·12 claims
- 1563US5428071APrevention and treatment of premalignant epithelial lesions and malignant tumors of epithelial originHOFFMANN LA ROCHE·Filed 1994·Granted Jun 27, 1995·28 cites·14 claims
- 1661US6589989B1Treatment of cell-mediated immune diseasesBASILEA PHARMACEUTICA AG·Filed 1998·Granted Jul 8, 2003·18 cites·8 claims
- 1760US4464394ACompositions and methods for using 13-cis vitamin A acid compoundsHOFFMANN LA ROCHE·Filed 1981·Granted Aug 7, 1984·18 cites·13 claims
- 1855US4163103ANovel derivatives of 9-substituted phenyl-3,7-dimethyl-nona-2,4,6,8-tetraeneHOFFMANN LA ROCHE·Filed 1978·Granted Jul 31, 1979·3 cites·1 claims
- 1954US4200647AVitamin A compositions to treat rheumatic diseaseHOFFMANN LA ROCHE·Filed 1978·Granted Apr 29, 1980·12 cites·8 claims
- 2053US2003176420A1Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonistsFiled 2003·Application pending·0 cites
- 2151US8541469B2Treatment of cell-mediated immune diseasesBOLLAG WERNER·Filed 2006·Granted Sep 24, 2013·0 cites·13 claims
- 2251US4532355ASubstituted triaryl phosphonium derivativesHOFFMANN LA ROCHE·Filed 1982·Granted Jul 30, 1985·2 cites·10 claims
- 2351US2006183737A1Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonistsBOLLAG WERNER·Filed 2006·Application pending·0 cites
- 2449US2005227967A1Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonistsBOLLAG WERNER·Filed 2005·Application pending·0 cites
- 2544US4319048ACertain 6-(3'-methoxyphenyl) derivatives of 2,4-hexadienalHOFFMANN LA ROCHE·Filed 1980·Granted Mar 9, 1982·1 cites·1 claims
- 2644US3931268AMethylhydrazinomethyl-substituted benzoic acid amidesHOFFMANN LA ROCHE·Filed 1970·Granted Jan 6, 1976·3 cites·8 claims
- 2744US2004039056A1Treatment of cell-mediated immune diseasesFiled 2003·Application pending·0 cites
- 2843US4719238ATreatment of diseases which cause pathological cornification of the epidermis of the skinHOFFMANN LA ROCHE·Filed 1987·Granted Jan 12, 1988·2 cites·10 claims
- 2942US4107190ANovel compounds of 9-phenyl-3,7-dimethyl-2,4,6,8-nonatetraenamideHOFFMANN LA ROCHE·Filed 1977·Granted Aug 15, 1978·1 cites·2 claims
- 3041US4187247A9-Substituted phenyl-3,7-dimethyl-nona 2,4,6,8-tetraene compoundsHOFFMANN LA ROCHE·Filed 1979·Granted Feb 5, 1980·1 cites·1 claims
- 3141US4044051A9[2-(1-Alkoxy-ethyl)-5,5-dimethyl-cyclopent-1-en-1-yl]-3,7-dimethyl-nona-2,4,6,8-tetraen acid compoundsHOFFMANN LA ROCHE·Filed 1975·Granted Aug 23, 1977·1 cites·3 claims
- 3239US2008255206A1Rxr Agonists and Antagonists, Alone or in Combination with Ppar Ligands, in the Treatment of Metabolic and Cardiovascular DiseasesBOLLAG WERNER·Filed 2006·Application pending·0 cites
- 3338US4863969ATreatment of premalignant lesions and certain malignant tumorsHOFFMANN LA ROCHE·Filed 1988·Granted Sep 5, 1989·5 cites·27 claims
- 3438US4689350ATreatment of dermatoses and illnesses producing inflammationHOFFMANN LA ROCHE·Filed 1986·Granted Aug 25, 1987·1 cites·10 claims
- 3536US2009016991A1Rxr Antagonist Treatment Against Multiple SclerosisBOLLAG WERNER·Filed 2005·Application pending·0 cites
- 3636US2008242729A1Rxr Antagonists in the Treatment of Inflammatory DiseasesBOLLAG WERNER·Filed 2005·Application pending·0 cites
- 3733US4267382A2,6-Dichloro-4-methoxy-5-methyl-benzene aldehydesHOFFMANN LA ROCHE·Filed 1980·Granted May 12, 1981·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Werner Bollag files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →